FNP/GYN – MENOPAUSE QUESTIONS
AND ANSWRES WITH COMPLETE
SOLUTIONS 100% CORRECT RATED A+
What is the median age at which women in the United States undergo natural
menopause?
✔✔ Answer: 51 years of age.
Under what age is the onset of menopause clinically classified as Primary
Ovarian Insufficiency (POI) or premature ovarian failure?
✔✔ Answer: Before reaching 40 years of age.
Which pituitary hormone experiences a distinct, initial rise during the
transition into menopause due to a lack of ovarian feedback?
✔✔ Answer: Follicle-stimulating hormone (FSH).
When evaluating an older patient presenting with amenorrhea, which
laboratory assessment is typically ordered to confirm a menopausal state?
✔✔ Answer: A serum FSH level.
Clinical Note: FSH is elevated during menopause; confirmation generally requires
multiple readings demonstrating levels greater than $30 \text{ IU/mL}$.
How does a decline in systemic estrogen levels negatively impact a patient's
cardiovascular and lipid profile?
✔✔ Answer: It results in a decline in high-density lipoprotein (HDL) ("good"
cholesterol), an increase in low-density lipoprotein (LDL) ("bad" cholesterol), and
adverse changes to the vascular endothelium (such as reduced nitric oxide
production and stiffer arterial walls).
How does the reduction of estrogen during menopause affect skeletal health?
✔✔ Answer: It triggers accelerated bone resorption (osteoclast activity outpaces
osteoblast activity), leading to a rapid decline in bone mineral density.
, postmenopausal women at 65 must be tested for ____. -ANSWER ✔✔bone
density; *osteopenia*; calcium and vitamin D
symptoms of menopause (7) -ANSWER ✔✔sleep disturbances, hot flashes,
vaginal dryness, atrophy of vaginal and vulvar epithelium;
Headache, nervousness, and depression
primary hormone replacement therapy -ANSWER ✔✔combination
estrogen/progesterone if patient has uterus
if patient is given estrogen alone and she has a uterus she is at risk for (2) -
ANSWER ✔✔endometrial hyperplasia and endometrial cancer
contraindications for hormone replacement therapy (5) -ANSWER ✔✔vaginal
bleeding; thromboembolic events; breast, ovarian or, uterine cancer ( known
estrogen dependent neoplasms); chronic liver failure; pregnancy.
initial treatment measures to consider in menopause (3) -ANSWER ✔✔HRT,
exercise, calcium and vitamin D
the main medication used for estrogen replacement therapy, the dosage range, the
most common initial dose? -ANSWER ✔✔Premarin, 0.3 mg-1.25 mg tablets,
0.625 mg and titrate
2 forms of estrogen therapy other than oral? -ANSWER ✔✔Vaginal estrogen
cream, transdermal estrogen patch
hot flash triggers (4) -ANSWER ✔✔alcohol, spicy food, facial heat, hot baths
AND ANSWRES WITH COMPLETE
SOLUTIONS 100% CORRECT RATED A+
What is the median age at which women in the United States undergo natural
menopause?
✔✔ Answer: 51 years of age.
Under what age is the onset of menopause clinically classified as Primary
Ovarian Insufficiency (POI) or premature ovarian failure?
✔✔ Answer: Before reaching 40 years of age.
Which pituitary hormone experiences a distinct, initial rise during the
transition into menopause due to a lack of ovarian feedback?
✔✔ Answer: Follicle-stimulating hormone (FSH).
When evaluating an older patient presenting with amenorrhea, which
laboratory assessment is typically ordered to confirm a menopausal state?
✔✔ Answer: A serum FSH level.
Clinical Note: FSH is elevated during menopause; confirmation generally requires
multiple readings demonstrating levels greater than $30 \text{ IU/mL}$.
How does a decline in systemic estrogen levels negatively impact a patient's
cardiovascular and lipid profile?
✔✔ Answer: It results in a decline in high-density lipoprotein (HDL) ("good"
cholesterol), an increase in low-density lipoprotein (LDL) ("bad" cholesterol), and
adverse changes to the vascular endothelium (such as reduced nitric oxide
production and stiffer arterial walls).
How does the reduction of estrogen during menopause affect skeletal health?
✔✔ Answer: It triggers accelerated bone resorption (osteoclast activity outpaces
osteoblast activity), leading to a rapid decline in bone mineral density.
, postmenopausal women at 65 must be tested for ____. -ANSWER ✔✔bone
density; *osteopenia*; calcium and vitamin D
symptoms of menopause (7) -ANSWER ✔✔sleep disturbances, hot flashes,
vaginal dryness, atrophy of vaginal and vulvar epithelium;
Headache, nervousness, and depression
primary hormone replacement therapy -ANSWER ✔✔combination
estrogen/progesterone if patient has uterus
if patient is given estrogen alone and she has a uterus she is at risk for (2) -
ANSWER ✔✔endometrial hyperplasia and endometrial cancer
contraindications for hormone replacement therapy (5) -ANSWER ✔✔vaginal
bleeding; thromboembolic events; breast, ovarian or, uterine cancer ( known
estrogen dependent neoplasms); chronic liver failure; pregnancy.
initial treatment measures to consider in menopause (3) -ANSWER ✔✔HRT,
exercise, calcium and vitamin D
the main medication used for estrogen replacement therapy, the dosage range, the
most common initial dose? -ANSWER ✔✔Premarin, 0.3 mg-1.25 mg tablets,
0.625 mg and titrate
2 forms of estrogen therapy other than oral? -ANSWER ✔✔Vaginal estrogen
cream, transdermal estrogen patch
hot flash triggers (4) -ANSWER ✔✔alcohol, spicy food, facial heat, hot baths
